Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04324112
Title Encorafenib Plus Binimetinib for People With BRAF V600E Mutated Relapsed/Refractory HCL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

hairy cell leukemia

Therapies

Binimetinib + Encorafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST